Vaishali Pharma Share Price

NSE
13.04
+0.59 (8.00%)
VAISHALI • 13 Jun, 2025 | 03:29 PM
BUY

1Y Annualised Return

-18.57%

3Y Annualised Return

16.49%

5Y Annualised Return

22.60%

The current prices are delayed, login or Open Demat Account for live prices.

Vaishali Pharma SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹59,29,851 (-8.77%)

Daily SIP of 25,000 would have become 59,29,851 in 1 year with a gain of -5,70,148 (-8.77%)

Vaishali Pharma Stock Performance
Today’s Low - High
12.26
13.05
12.26
13.05
52 Week Low - High
10.30
24.91
10.30
24.91

Open

12.46

Prev. Close

12.45

Total Traded Value

1.75 Cr

View details of Market Depth
Vaishali Pharma Fundamental

Market Cap (in crs)

139.14

Face Value

2

Turnover (in lacs)

175.42

Key Metrics
Qtr Change %
47.89% Fall from 52W High
7.1
Dividend yield 1yr %
0

Vaishali Pharma shareholding Pattern

Promoter
26.3%
Public
73.7%
Promoter
26.3%
Public
73.7%
Promoter
26.3%
Public
73.7%
Promoter
26.3%
Public
73.7%
Promoter
26.3%
Public
73.7%
Promoter
26.6%
Public
73.4%

Vaishali Pharma Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
13.04
Current Price
Bullish Moving Averages
11
Bearish Moving Averages
5
5Day EMA
12.80
10Day EMA
12.80
12Day EMA
12.80
20Day EMA
12.80
26Day EMA
12.80
50Day EMA
12.90
100Day EMA
13.70
200Day EMA
14.70
5Day SMA
12.80
10Day SMA
12.80
20Day SMA
12.80
30Day SMA
12.60
50Day SMA
12.70
100Day SMA
13.60
150Day SMA
14.90
200Day SMA
16.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
1043621 Rs
1351460 Rs
Week Rs
561924 Rs
826686 Rs
Month Rs
362959 Rs
557843 Rs
Resistance & Support
12.76
Pivot
Resistance
First Resistance
13.27
Second Resistance
13.55
Third Resistance
14.06
Support
First Support
12.48
Second support
11.97
Third Support
11.69
Relative Strength Index
53.59
Money Flow Index
43.79
MACD
0.01
MACD Signal
0.02
Average True Range
0.66
Average Directional Index
8.81
Rate of Change (21)
5.79
Rate of Change (125)
-34.34

Vaishali Pharma Company background

Founded in: 2008
Managing director: Atul Vasani
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries of which dossier is in CTD format along with itsrespective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Companys synergistic collaboration with WHOGMP manufacturing facilities is backed by an excellent rapport with clients.In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments Medical Devices Directive. In addition, the Company has also been recognized by Government of India as One Star Export House and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.

As of 13 Jun, 2025, VAISHALI share price is ₹13. The stock opened at ₹12.5 and had closed at ₹12.4 the previous day. During today’s trading session, VAISHALI share price moved between ₹12.26 and ₹13.05, with an average price for the day of ₹12.50. Over the last 52 weeks, the stock has recorded a low of ₹10.30 and a high of ₹24.91. In terms of performance, VAISHALI share price has declined by 35.5% over the past six months and has declined by 18.57% over the last year.

Read More

Vaishali Pharma FAQs

Vaishali Pharma share price in the past 1-year return was -15.1. The Vaishali Pharma share hit a 1-year low of Rs. 10.3 and a 1-year high of Rs. 24.91.

The market cap of Vaishali Pharma is Rs. 139.14 Cr. as of 13/6/2025.

The PE ratios of Vaishali Pharma is 162.25 as of 13/6/2025.

The PB ratios of Vaishali Pharma is 2.3 as of 13/6/2025

You can easily buy Vaishali Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Vaishali Pharma stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -